3rd Quarter - Report

SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE for SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education. H.R.3070/S.1599, Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2012, and for other purposes, primarily matters related to appropriations for cancer research and cancer screening programs. H.R.2219/Senate companion bill, Department of Defense Appropriations Act, related to appropriations for Congressional Directed Medical Research Programs. H.R.466/S. 384, Breast Cancer Research Stamp Reauthorization Act. H.R.2245/S.296, Preserving Access to Life-Saving Medications Act of 2011, primarily matters related to cancer treatments. H.R.2499, Lymphedema Diagnosis and Treatment Cost-Saving Act of 2011. Pub. Law No. 112-25, the Budget Control Act of 2011, primarily matters related to funding of cancer research and breast cancer programs. H.R.2746, Cancer Drug Coverage Parity Act of 2011. H.R.111, Breast Cancer Patient Protection Act of 2011

LobbyistCovered position, as disclosed
ALLISON COHEN New —
KAREN HANDEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 2245 (112th), S. 384 (112th), H.R. 111 (112th), H.R. 3070 (112th), S. 296 (112th), H.R. 2499 (112th), H.R. 466 (112th), H.R. 2219 (112th), H.R. 2746 (112th), S. 1599 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.